Cactus Life Sciences Top 5 Trends of 2024

Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms

Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence the ever-evolving biopharma landscape...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...
Patient Inclusivity Survey - PM360 and Cactus Life Sciences

Patient Inclusivity Survey

How many life sciences companies are actually making an effort to include patients in things...
Why the Healthcare Industry MUST Care About the Caregiver

Why the Healthcare Industry MUST Care about the Caregiver

Caregivers are vital in the treatment of a patient, whether at home or in a...
Image - Understanding Patient Centricity, Progress Made, and Barriers Encountered Survey Questionnaire and Responses

Survey Report: Understanding Patient Centricity, Progress Made, and Barriers Encountered (Survey Questionnaire and Responses)

Cactus Communications commissioned a survey of pharma/biotech and associated industry professionals to understand the progress...
How Can Preprints Drive Trust In Science?

How Can Preprints Drive Trust in Science?

By tagging preprints with various indicators, badges may represent quality, rigor, and scope. In doing...
Publication planning training

Publication Planning Training for Regional Medical Affairs Team

How a global pharma company overcame challenges of integration with regional teams in terms of...
The battle for evidence-based truth in a war of misinformation

The Battle for Evidence-Based Truth in a War of Misinformation

I was talking to someone I know — let’s call her Joanna — about the...

Learn more ABOUT our company.